** Shares of Microba Life Sciences MAP.AX fall 17.8% to A$0.185
** Stock set for its weakest session since October 23, 2023- if current trends hold
** Health sciences co posts a 15% decline in Q3 revenue compared to last year
** But, co sees FY25 revenue to be up 26%-34% from last year
** Co set for its strongest month since January
** About 559,491 shares change hands, 3.7x the 30-day average of 152,712 shares
** Stock down 5.1% YTD, including current session's moves
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.